The U.S. molecular biology enzymes, reagents, and kits market, valued at USD 5.73 billion in 2024 and expanding at a 10.3% CAGR from 2025 to 2034, is undergoing a transformation defined not by uniform growth but by sharp divergences across product segments and application domains. While the market as a whole benefits from rising genomic research and diagnostic demand, segment-wise performance...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek